-
Metformin use in obese mothers is associated with improved cardiovascular profile in the offspring.
Panagiotopoulou O, Syngelaki A, Georgiopoulos G, Simpson J, Akolekar R, Shehata H, Nicolaides K, Charakida M.
Am J Obstet Gynecol 2020;223:246.e1-246.e10. pdf -
Metformin in Pregnancy Study (MiPS): protocol for a systematic review with individual patient data meta-analysis.
Mousa A, Løvvik T, Hilkka I, Carlsen SM, Morin-Papunen L, Tertti K, Rönnemaa T, Syngelaki A, Nicolaides K, Shehata H, Burden C, Norman JE, Rowan J, Dodd JM, Hague W, Vanky E, Teede HJ.
BMJ Open 2020;10:e036981. pdf -
Association between insulin resistance and preeclampsia in obese non-diabetic women receiving metformin.
Balani J, Hyer S, Syngelaki A, Akolekar R, Nicolaides KH, Johnson A, Shehata H.
Obstet Med 2017;10:170-173. pdf -
Metformin versus Placebo in Obese Pregnant Women without Diabetes Mellitus.
Syngelaki A, Nicolaides KH, Balani J, Hyer S, Akolekar R, Kotecha R, Pastides A, Shehata H.
N Engl J Med 2016;374:434-43 pdf